OPKO Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2024 Annual Meeting of Stockholders held by OPKO Health, Inc. on March 28, 2024. The filing details the outcomes of four specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following material actions were approved by stockholders:
- Election of Directors: All eleven nominees were elected to the Board of Directors. Votes ranged from approximately 409 million to 438 million "For" votes per director.
- Authorized Share Increase: Stockholders approved an amendment to the certificate of incorporation to increase the authorized number of Common Stock shares from 1,000,000,000 to 1,250,000,000. The proposal received 492,393,778 "For" votes versus 37,918,739 "Against" votes.
- Executive Compensation: Stockholders approved, on a non-binding advisory basis, the compensation of named executive officers. The proposal received 431,121,613 "For" votes versus 13,954,192 "Against" votes.
- Appointment of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The proposal received 519,634,618 "For" votes versus 10,186,987 "Against" votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the updated authorized share count of 1,250,000,000 in the company's charter.
- Confirm the composition of the newly elected Board of Directors.
- Review the 2024 Proxy Statement for details on the executive compensation package that was approved.
- Confirm the engagement of Ernst & Young LLP for the 2024 fiscal year audit.